Tcg Crossover Management, LLC Centessa Pharmaceuticals PLC Transaction History
Tcg Crossover Management, LLC
- $415 Million
- Q1 2025
A detailed history of Tcg Crossover Management, LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 2,890,816 shares of CNTA stock, worth $36.9 Million. This represents 10.01% of its overall portfolio holdings.
Number of Shares
2,890,816
Previous 2,890,816
-0.0%
Holding current value
$36.9 Million
Previous $48.4 Million
14.15%
% of portfolio
10.01%
Previous 7.91%
Shares
2 transactions
Others Institutions Holding CNTA
# of Institutions
138Shares Held
124MCall Options Held
163KPut Options Held
338K-
Medicxi Ventures Management (Jersey) LTD20MShares$255 Million75.25% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$127 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$123 Million4.7% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.95MShares$88.7 Million0.19% of portfolio
-
Janus Henderson Group PLC London, X05.92MShares$75.5 Million0.05% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.2B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...